A GLP-1/glucagon dual agonist conferred weight loss of up to 12.55% at 32 weeks for adults with overweight or obesity, ...

The high dose of Wegovy is one part of Novo Nordisk's plan to defend its obesity business, along with a major ...

A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...

A MOUNJARO user has candidly opened up on what happened after she used fat jabs for just four weeks. Despite being “really happy” with losing two to three lbs a week on the injections, Megan ...

For many, the high cost of the pill means stopping is a matter of 'when,' not 'if.' Endocrinologists reveal the crucial steps ...

Weight loss jabs will not be enough to make “lasting progress” on tackling the obesity epidemic, leading medics have said.

ASA said the advert posted to her Instagram, which is still live, would 'likely' encourage people to 'request the ...

Weight loss injections will not be enough to make “lasting progress” in tackling the obesity epidemic, leading medical experts have warned.

More than 100 million Americans who qualify as overweight could see themselves tip into the obese category under newly ...

Stocktwits - Danish pharmaceutical company Novo Nordisk (CSE: NOVOb) (NVO) on Tuesday said that it has submitted an ...

Reduced monthly costs for uninsured patients still amount to around $500. That can put the drugs out of reach for many.